A prospective double-blind cross-sectional study of the accuracy of the use of dry vaginal tampons for self-sampling of human papillomaviruses

被引:5
|
作者
Khan, A. M. [1 ,2 ]
Sasieni, P. [3 ]
Singer, A. [1 ]
机构
[1] UCL, Sch Med, London W1N 8AA, England
[2] Whittington Hlth NHS, ICO, Womens Hlth Div, London N19 5NF, England
[3] Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England
关键词
Cervical intraepithelial neoplasia; human papillomavirus test; polymerase chain reaction-based human papillomavirus test; self sampling; vaginal tampon to detect human papillomavirus; NORMAL COLPOSCOPY; LOW-GRADE; HIGH-RISK; WOMEN; MANAGEMENT; ABNORMALITIES; GUIDELINES; LESIONS; SMEARS; HPV16;
D O I
10.1111/1471-0528.12926
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To evaluate if a dry vaginal tampon can be used to accurately detect high-risk human papillomaviruses (HPV) and so be used as a cervical screening tool for the early detection of high-grade cervical intraepithelial neoplasia (CIN2+). Design Prospective double-blinded cross-sectional study. Setting Colposcopy unit in North London. Population Women referred for colposcopy with both abnormal and normal cervical cytology were invited to participate in this study. Methods Women inserted a dry tampon in the vagina before colposcopic examination. Polymerase chain reaction (PCR) HPV test was carried out on the dry tampon. Cervical samples were collected by the colposcopist for HPV testing using Hybrid Capture (an HC2 kit). Main outcome measure Detection of CIN2+. Results In all, 501 women participated in the study. The majority of participants (69%) were in the 25-35-year age group. Overall sensitivity and specificity for detection of CIN2+ by vaginal tampon were 76% (95% confidence interval [95% CI] 65-85) and 61% (95% CI 56-66), respectively, and HC2 had a sensitivity of 92% (95% CI 83-97) with a specificity of only 46% (95% CI 4151). Sensitivity ratio was 0.83 (95% CI 0.73-0.94) (P = 0.004) and Specificity ratio for CIN2+ was 1.33 (95% CI 1.22-1.45). Indicating that the tampon test was significantly (P < 0.0001) more specific. Sensitivity decreased and specificity improved with increasing age. Conclusions Dry tampon test showed reasonably high sensitivity and specificity when detecting CIN2+. The majority of participants (98%) approved of the use of dry tampons as a method of sample collection, which could be an effective alternative method for detecting HPV infection.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 50 条
  • [11] The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study
    Song, Jia
    Ni, Yi-Hua
    Fang, Jing
    Qu, Shui-Xiang
    Chen, Xiao-Yan
    Wu, Wei-Li
    Zhang, Wei-Chu
    Qin, Jian-Fen
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [12] Cross-Sectional Study of HPV Self-Sampling among Indian Women-A Way Forward
    Anand, Kavita, V
    Mishra, Gauravi A.
    Pimple, Sharmila A.
    Biswas, Sanjay K.
    Kulkarni, Vasundhara Y.
    Salunke, Gaurav
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (01) : 103 - 108
  • [13] Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study
    Noely Paula Cristina Lorenzi
    Lara Termini
    Adhemar Longatto Filho
    Maricy Tacla
    Lana Maria de Aguiar
    Mariana Carmezim Beldi
    Edson Santos Ferreira-Filho
    Edmund Chada Baracat
    José Maria Soares-Júnior
    BMC Public Health, 19
  • [14] HPV self-sampling acceptability among women in Italy: preliminary results of a cross-sectional study
    Angelillo, S.
    Licata, F.
    Errico, E. A.
    Maruca, R.
    Freccia, S.
    Pujia, R.
    Di Gennaro, G.
    Bianco, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32 : 638 - 638
  • [15] Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study
    Cristina Lorenz, Noely Paula
    Termini, Lara
    Longatto Filho, Adhemar
    Tacla, Maricy
    de Aguiar, Lana Maria
    Beldi, Mariana Carmezim
    Ferreira-Filho, Edson Santos
    Baracat, Edmund Chada
    Soares-Junior, Jose Maria
    BMC PUBLIC HEALTH, 2019, 19 (1) : 963
  • [16] Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England
    Drysdale, Hannah
    Marlow, Laura A., V
    Lim, Anita
    Sasieni, Peter
    Waller, Jo
    JOURNAL OF MEDICAL SCREENING, 2022, 29 (03) : 194 - 202
  • [17] Diagnostic Accuracy of Positron Emission Tomography/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double-Blind, Cross-Sectional Study
    Sammel, Anthony M.
    Hsiao, Edward
    Schembri, Geoffrey
    Nguyen, Katherine
    Brewer, Janice
    Schrieber, Leslie
    Janssen, Beatrice
    Youssef, Peter
    Fraser, Clare L.
    Bailey, Elizabeth
    Bailey, Dale L.
    Roach, Paul
    Laurent, Rodger
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (08) : 1319 - 1328
  • [18] A PROSPECTIVE STUDY TO EVALUATE THE AGREEMENT OF HIGH-RISK HUMAN PAPILLOMAVIRUS DETECTIONS BY VAGINAL SELF-SAMPLING AND PHYSICIAN-SAMPLING
    Huang, Huei-Jean
    Chou, Hung-Hsueh
    Lai, Chyong-Huey
    Wu, Ren-Chin
    Yang, Lan-Yan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A42 - A42
  • [19] Self-sampling and HPV DNA testing for cervical precancer screening in a cohort of nuns in Ghana: a cross-sectional cohort study
    Effah, Kofi
    Tekpor, Ethel
    Amuah, Joseph Emmanuel
    Essel, Nana Owusu M.
    Kemawor, Seyram
    Morkli, Esu Aku Catherine
    Lamptey-Mills, Esther
    Wormenor, Comfort Mawusi
    Manu, Lawrencia Serwaa
    Klutsey, Gifty Belinda
    Danyo, Stephen
    Kafuiakakpo, Patrick
    ECLINICALMEDICINE, 2023, 63
  • [20] Experiences of Self-Sampling and Future Screening Preferences in Non-Attenders Who Returned an HPV Vaginal Self-Sample in the YouScreen Study: Findings From a Cross-Sectional Questionnaire
    Drysdale, Hannah
    Marlow, Laura A. V.
    Lim, Anita
    Waller, Jo
    HEALTH EXPECTATIONS, 2024, 27 (04)